#USA #New York #Class Action #Levi & Korsinsky #Replimune Group

Class Action Alert: Replimune Group, Inc. Overview

Levi & Korsinsky, LLP recently issued a notification regarding a pending class action lawsuit for investors of Replimune Group, Inc. (NASDAQ: REPL). The lawsuit pertains to allegations of securities fraud that affected shareholders during the period from November 22, 2024, to July 21, 2025. With a lead plaintiff deadline set for September 22, 2025, impacted investors are encouraged to act soon to participate in this legal motion.

Class Definition

This class action seeks financial recovery for investors who suffered losses due to claims against Replimune Group, Inc. The complaint alleges the defendants involved made misleading statements that significantly inflated the company's trial prospects, particularly concerning the IGNYTE trial. As a result, these false representations led the FDA to deem the trial inadequate.

Case Details

The filed lawsuit presents evidence of allegations that the defendants recklessly overstated the IGNYTE trial's potential, despite being aware of serious underlying issues. It further asserts that the consistently positive statements about Replimune's operations and prospects were fundamentally unfounded. The core claims revolve around the failure to disclose critical information which ultimately misled investors.

Important Dates

If you believe you are part of this affected group, the deadline to request that the court appoint you as a lead plaintiff is September 22, 2025. It’s crucial to note that participating in this class action does not necessitate serving as a lead plaintiff to be eligible for any potential recovery in the lawsuit.

No Financial Risk

For individuals who qualify as class members, participation in the lawsuit entails no upfront costs or obligations. Levi & Korsinsky indicates that any compensation awarded will not require out-of-pocket expenses from participants, ensuring that investors can contribute with no financial risk.

Why Choose Levi & Korsinsky?

Levi & Korsinsky boasts over two decades of experience, having recovered hundreds of millions of dollars for investors. The firm specializes in complex securities litigation and has consistently ranked among the top firms in the United States for class action litigation. With a dedicated team of over 70 professionals, they are well-equipped to represent investors in high-stakes cases effectively.

Contact Information

Affected investors are encouraged to contact Levi & Korsinsky for further information. Joseph E. Levi, Esq. can be reached via email at [email protected] or by phone at (212) 363-7500.

Conclusion

As the deadline for the lead plaintiff decision approaches, investors in Replimune Group, Inc. should ensure they are informed about their rights and the necessary steps to join the class action lawsuit. The potential for recovery of losses due to the alleged misleading practices makes it important for affected parties to take action promptly. For more details about the case and to get involved, refer to the provided information or contact Levi & Korsinsky directly.